Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Amorphical Ltd. is active in the Chemistry & Materials technology area with 1 pending office action. This single active matter suggests a focused prosecution strategy for the company's chemical innovations. The firm is currently working to resolve this action to move its application toward allowance.
The portfolio is being reviewed by 1 distinct examiner and 1 distinct art unit. This indicates that the company's current intellectual property is concentrated within a specific technical classification at the patent office. The lack of diversity in examiners and art units means that the prosecution process is consistent, with a single set of standards being applied to the pending matter.
PHAN, ANNETTE HOANG-ANH is the busiest examiner for this portfolio. This examiner is responsible for the 1 busiest examiner pending office action. Since PHAN, ANNETTE HOANG-ANH handles the only active matter, this individual is the primary gatekeeper for the company's current patent goals. Practitioners should prioritize understanding the specific examination style of PHAN, ANNETTE HOANG-ANH to successfully resolve the 1 pending office action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PHAN, ANNETTE HOANG-ANH | 1 | 71.7% | +9.8% |
| HELM, CARALYNNE E | 1 | 28.9% | +49.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909549 | AMORPHOUS CALCIUM CARBONATE FOR TREATMENT OF ACIDOSIS | HELM, CARALYNNE E | 12d |
| 18227077 | PARTICLES COMPRISING AMORPHOUS DIVALENT METAL CARBONATE | PHAN, ANNETTE HOANG-ANH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909549 | AMORPHOUS CALCIUM CARBONATE FOR TREATMENT OF ACIDOSIS | HELM, CARALYNNE E | 12d |
| Art Unit | Apps |
|---|---|
| 1736 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18227077 | PARTICLES COMPRISING AMORPHOUS DIVALENT METAL CARBONATE | PHAN, ANNETTE HOANG-ANH | 1736 | §102§103 | Non-Final OA | — | Pending | Jul 27, 2023 |
| 17909549 | AMORPHOUS CALCIUM CARBONATE FOR TREATMENT OF ACIDOSIS | HELM, CARALYNNE E | 1615 | §103 | Final Rejection | 12d | Pending | Sep 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial